[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100599049":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":42,"centralContacts":42,"locations":42,"responsibleParty":43,"collaborators":42,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":42,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":71,"overallStatus":76,"whyStopped":42,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":42},{"fullName":5,"class":6},"Fudan University","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm A: 0.25% Ropivacaine for Intercostal Nerve Blockade","EXPERIMENTAL","The in-plane technique was adopted, with the needle inserted 5 mm away from the long axis of the probe. During the operation, the long axis of the needle and the needle tip were displayed in real time. When the needle tip reached the extrapleural space, between the internal intercostal muscle (internal intercostal membrane) and the innermost intercostal muscle at the lower edge of the rib, and no blood was aspirated, ropivacaine (Naropin 10ml:75mg) of corresponding concentration and volume was injected into each group. Anechoic fluid was observed to spread under the internal intercostal muscle, and as the volume of the injected fluid increased, the local parietal pleura gradually descended. Inject 4 ml of 0.25% ropivacaine into each intercostal space.",[13],"Drug: 0.25% ropivacaine",{"label":15,"type":10,"description":16,"interventionNames":17},"Arm B: 0.375% Ropivacaine for Intercostal Nerve Blockade","The in-plane technique was adopted, with the needle inserted 5 mm away from the long axis of the probe. During the operation, the long axis of the needle and the needle tip were displayed in real time. When the needle tip reached the extrapleural space, between the internal intercostal muscle (internal intercostal membrane) and the innermost intercostal muscle at the lower edge of the rib, and no blood was aspirated, ropivacaine (Naropin 10ml:75mg) of corresponding concentration and volume was injected into each group. Anechoic fluid was observed to spread under the internal intercostal muscle, and as the volume of the injected fluid increased, the local parietal pleura gradually descended. Inject 4 ml of 0.375% ropivacaine into each intercostal space.",[18],"Drug: 0.375% Ropivacaine",{"label":20,"type":10,"description":21,"interventionNames":22},"Arm C: 0.5% Ropivacaine for Intercostal Nerve Blockade","The in-plane technique was adopted, with the needle inserted 5 mm away from the long axis of the probe. During the operation, the long axis of the needle and the needle tip were displayed in real time. When the needle tip reached the extrapleural space, between the internal intercostal muscle (internal intercostal membrane) and the innermost intercostal muscle at the lower edge of the rib, and no blood was aspirated, ropivacaine (Naropin 10ml:75mg) of corresponding concentration and volume was injected into each group. Anechoic fluid was observed to spread under the internal intercostal muscle, and as the volume of the injected fluid increased, the local parietal pleura gradually descended. Inject 4 ml of 0.5% ropivacaine into each intercostal space.",[23],"Drug: 0.5% Ropivacaine",[25,32,37],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DRUG","0.25% ropivacaine","During breast quadrantectomy, intercostal nerve block is performed at the 2nd to 6th intercostal spaces along the posterior axillary line using an in-plane technique. 4ml of 0.25% ropivacaine (prepared from Naropin, 10ml:75mg) is injected into each intercostal space. Under ultrasound guidance, the needle tip is ensured to reach the space between the internal intercostal muscle (intercostal endomysium) and the innermost intercostal muscle below the rib margin. After aspiration shows no blood, the drug is injected, and anechoic fluid can be seen diffusing below the internal intercostal muscle, with the local parietal pleura gradually descending as the injected fluid volume increases.",[9],[31],"Ropivacaine Hydrochloride Injection , Naropin , AstraZeneca AB, Sweden",{"type":26,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"0.375% Ropivacaine","During breast quadrantectomy, intercostal nerve block is performed at the 2nd to 6th intercostal spaces along the posterior axillary line using an in-plane technique. 4ml of 0.375% ropivacaine (prepared from Naropin, 10ml:75mg) is injected into each intercostal space. Under ultrasound guidance, the needle tip is ensured to reach the space between the internal intercostal muscle (intercostal endomysium) and the innermost intercostal muscle below the rib margin. After aspiration shows no blood, the drug is injected, and anechoic fluid can be seen diffusing below the internal intercostal muscle, with the local parietal pleura gradually descending as the injected fluid volume increases.",[15],[31],{"type":26,"name":38,"description":39,"armGroupLabels":40,"otherNames":41},"0.5% Ropivacaine","During breast quadrantectomy, intercostal nerve block is performed at the 2nd to 6th intercostal spaces along the posterior axillary line using an in-plane technique. 4ml of 0.5% ropivacaine (prepared from Naropin, 10ml:75mg) is injected into each intercostal space. Under ultrasound guidance, the needle tip is ensured to reach the space between the internal intercostal muscle (intercostal endomysium) and the innermost intercostal muscle below the rib margin. After aspiration shows no blood, the drug is injected, and anechoic fluid can be seen diffusing below the internal intercostal muscle, with the local parietal pleura gradually descending as the injected fluid volume increases.",[20],[31],null,{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":42,"oldOrganization":42},"PRINCIPAL_INVESTIGATOR","Jun Zhang","Doc.","100599049","eit-evaluation-of-pulmonary-ventilation-with-different-ropivacaine-concentrations-in-intercostal-nerve-blockade-100599049",false,"NCT07079436","EIT Evaluation of Pulmonary Ventilation With Different Ropivacaine Concentrations in Intercostal Nerve Blockade","Electrical Impedance Tomography (EIT) to Evaluate the Effect of Different Concentrations of Ropivacaine on Pulmonary Ventilation Function During Intercostal Nerve Blockade","EIT","Inclusion Criteria:\n\n* Patients scheduled for elective breast quadrantectomy;\n* Aged 18-80 years;\n* American Society of Anesthesiologists (ASA) physical status I-II;\n* Body mass index (BMI) \\\u003C35 kg\u002Fm².\n\nExclusion Criteria:\n\n* Contraindications for nerve block: infection at the puncture site, local anesthetic allergy, coagulation dysfunction or bleeding risk;\n* Patients with unilateral diaphragmatic paralysis;\n* Patients with severe ventilatory or gas exchange dysfunction;\n* Complicated with acute or chronic pulmonary and bronchial diseases, sleep apnea syndrome;\n* Mental disorders;\n* Patients who refuse to participate;\n* Patients whom the researchers consider unsuitable for the clinical trial, with reasons to be specified.","FEMALE","18 Years","80 Years",{"count":59,"type":60},72,"ESTIMATED","INTERVENTIONAL",[63],"NA","This study aims to find out how different strengths of the anesthetic drug ropivacaine affect lung breathing function when used in intercostal nerve block (a type of local anesthesia) for breast quadrantectomy surgery. Researchers will use a non-invasive imaging technique called electrical impedance tomography (EIT) to monitor lung ventilation in real time.\n\nWhy is this study being done? Intercostal nerve block is a common anesthesia method for breast surgeries, but the ideal strength of ropivacaine that balances effective pain relief with safety for lung function is not fully clear. EIT can help measure how each drug strength affects breathing by showing changes in lung airflow.\n\nWhat will happen in the study? Participants: 72 adults scheduled for breast quadrantectomy, aged 18-80, will be randomly assigned to receive one of three ropivacaine strengths (0.25%, 0.375%, or 0.5%) during intercostal nerve block.\n\nProcedures: After anesthesia, EIT will monitor lung ventilation before and after the block. Researchers will measure:\n\nHow much each lung side contributes to breathing during quiet and deep breaths. How quickly the anesthesia works, pain levels during surgery, and any side effects (like difficulty breathing or allergic reactions).\n\nWho can join? Adults having elective breast quadrantectomy. ASA physical status I-II (generally healthy to mildly ill). BMI \\\u003C35 kg\u002Fm². No history of nerve block allergies, breathing problems, or certain lung diseases.\n\nWhat are the possible benefits? The study may help doctors choose the best ropivacaine strength to ensure good pain control while minimizing risks to lung function, especially for same-day surgery patients.\n\nWhat are the risks? Potential risks include rare side effects from the anesthetic (like allergic reactions or low blood pressure) or temporary breathing changes, which will be closely monitored.\n\nHow is the study designed? This is a double-blind, randomized trial (neither patients nor doctors know which drug strength is used) at Fudan University Shanghai Cancer Center.",[66,67,68,69,70],"Intercostal Nerve Block","Pulmonary Ventilation","Anesthesia, Local","Breast Neoplasms","Surgical Procedures, Operative",[72,66,73,74,75,69],"Ropivacaine","Pulmonary Ventilation Function","Electrical Impedance Tomography","Anesthetic Concentration","NOT_YET_RECRUITING","2025-07-22",{"date":79,"type":80},"2025-07-23","ACTUAL",{"date":82,"type":60},"2025-08-10",{"date":84,"type":60},"2025-12-31",{"name":5,"class":6}]